BTW
CL icon

Boston Trust Walden’s Colgate-Palmolive CL Stock Holding History

Boston Trust Walden’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20M Buy
218,500
+58,190
+36% +$5.09M 0.15% 177
2026
Q1 		$13.7M Sell
160,310
-9,808
-6% -$874K 0.11% 199
2025
Q4 		$13.4M Buy
170,118
+7,434
+5% +$583K 0.1% 192
2025
Q3 		$13M Sell
162,684
-76,415
-32% -$6.52M 0.1% 195
2025
Q2 		$21.7M Buy
239,099
+10,961
+5% +$1M 0.16% 168
2025
Q1 		$21.4M Buy
228,138
+29,320
+15% +$2.63M 0.16% 174
2024
Q4 		$18.1M Sell
198,818
-22,045
-10% -$2.1M 0.13% 180
2024
Q3 		$22.9M Sell
220,863
-1,948
-0.9% -$199K 0.16% 169
2024
Q2 		$21.6M Sell
222,811
-6,206
-3% -$572K 0.16% 164
2024
Q1 		$20.6M Sell
229,017
-6,353
-3% -$538K 0.15% 170
2023
Q4 		$18.8M Sell
235,370
-6,370
-3% -$479K 0.14% 171
2023
Q3 		$17.2M Sell
241,740
-4,703
-2% -$352K 0.14% 173
2023
Q2 		$19M Sell
246,443
-4,515
-2% -$349K 0.16% 167
2023
Q1 		$18.9M Sell
250,958
-37,565
-13% -$2.79M 0.16% 173
2022
Q4 		$22.7M Buy
288,523
+21,050
+8% +$1.58M 0.2% 161
2022
Q3 		$18.8M Buy
267,473
+4,060
+2% +$318K 0.19% 168
2022
Q2 		$21.1M Buy
263,413
+4,580
+2% +$358K 0.2% 162
2022
Q1 		$19.6M Sell
258,833
-9,695
-4% -$768K 0.16% 174
2021
Q4 		$22.9M Buy
268,528
+11,327
+4% +$885K 0.18% 172
2021
Q3 		$19.4M Sell
257,201
-41,036
-14% -$3.26M 0.17% 172
2021
Q2 		$24.3M Buy
298,237
+13,595
+5% +$1.11M 0.22% 160
2021
Q1 		$22.4M Sell
284,642
-235,110
-45% -$18.4M 0.22% 154
2020
Q4 		$44.4M Sell
519,752
-16,699
-3% -$1.38M 0.47% 65
2020
Q3 		$41.4M Sell
536,451
-2,068
-0.4% -$158K 0.52% 55
2020
Q2 		$39.5M Sell
538,519
-13,045
-2% -$927K 0.53% 52
2020
Q1 		$36.6M Sell
551,564
-27,277
-5% -$1.92M 0.58% 48
2019
Q4 		$39.8M Sell
578,841
-19,819
-3% -$1.35M 0.46% 64
2019
Q3 		$44M Sell
598,660
-11,027
-2% -$800K 0.55% 52
2019
Q2 		$43.7M Buy
609,687
+7,908
+1% +$561K 0.57% 47
2019
Q1 		$41.2M Buy
601,779
+24,314
+4% +$1.57M 0.56% 49
2018
Q4 		$34.4M Sell
577,465
-6,036
-1% -$378K 0.55% 53
2018
Q3 		$39.1M Buy
583,501
+9,663
+2% +$644K 0.54% 55
2018
Q2 		$37.2M Buy
573,838
+26,235
+5% +$1.72M 0.55% 57
2018
Q1 		$39.3M Sell
547,603
-37,467
-6% -$2.7M 0.6% 47
2017
Q4 		$44.1M Sell
585,070
-13,690
-2% -$1,000K 0.65% 42
2017
Q3 		$43.6M Sell
598,760
-2,483
-0.4% -$179K 0.68% 42
2017
Q2 		$44.6M Buy
601,243
+13,348
+2% +$991K 0.72% 39
2017
Q1 		$43M Buy
587,895
+14,760
+3% +$1.03M 0.67% 40
2016
Q4 		$37.5M Buy
573,135
+3,745
+0.7% +$257K 0.59% 49
2016
Q3 		$42.2M Sell
569,390
-3,258
-0.6% -$241K 0.7% 38
2016
Q2 		$41.9M Buy
572,648
+6,065
+1% +$432K 0.72% 38
2016
Q1 		$40M Sell
566,583
-5,368
-0.9% -$357K 0.7% 36
2015
Q4 		$38.1M Sell
571,951
-53,123
-8% -$3.53M 0.71% 34
2015
Q3 		$39.7M Sell
625,074
-20,092
-3% -$1.31M 0.66% 39
2015
Q2 		$42.2M Sell
645,166
-41,666
-6% -$2.83M 0.64% 41
2015
Q1 		$47.6M Sell
686,832
-3,637
-0.5% -$251K 0.71% 36
2014
Q4 		$47.8M Sell
690,469
-2,005
-0.3% -$135K 0.71% 40
2014
Q3 		$45.2M Sell
692,474
-2,665
-0.4% -$176K 0.7% 41
2014
Q2 		$47.4M Sell
695,139
-6,940
-1% -$465K 0.69% 43
2014
Q1 		$45.5M Buy
702,079
+6,240
+0.9% +$393K 0.68% 48
2013
Q4 		$45.4M Buy
695,839
+243
+0% +$15.6K 0.66% 57
2013
Q3 		$41.2M Sell
695,596
-5,510
-0.8% -$326K 0.63% 55
2013
Q2 		$40.2M Buy
+701,106
New +$41.6M 0.65% 56

Other funds holding CL

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
JIC
Johnson Investment Counsel Cincinnati, Ohio $13.7B AUM 21.52% 1-Year Est. Return
WG
Welch Group Birmingham, Alabama $2.93B AUM 27.62% 1-Year Est. Return

Boston Trust Walden's CL Position: Q2 2026 in Review

Boston Trust Walden increased its Colgate-Palmolive (CL) stake by 36% in Q2 2026, buying an estimated $5.09M and bringing the position to 218,500 shares worth $20M. The position accounts for 0.15% of the portfolio, ranked #177.

Boston Trust Walden first reported a position in CL in Q2 2013 and has held it in 53 quarters since. The position peaked at $47.8M in Q4 2014. 597 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Boston Trust Walden held 218,500 shares of Colgate-Palmolive worth $20M as of Q2 2026.
  • Boston Trust Walden bought 58,190 Colgate-Palmolive shares in Q2 2026, an estimated $5.09M.
  • Colgate-Palmolive made up 0.15% of Boston Trust Walden's portfolio in Q2 2026, its #177 holding.
  • Boston Trust Walden first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 53 quarters since.
  • Boston Trust Walden's Colgate-Palmolive position peaked at $47.8M in Q4 2014.
  • 597 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Boston Trust Walden's 13F filing for Q2 2026, filed 24 Jul 2026.